You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial

Article metrics

Article menu
Cardiovascular medicine
Protocol
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial

 

Online download statistics by month:

Online download statistics by month: February 2022 to June 2025

AbstractFullPdf
Feb 202244745772
Mar 2022276277141
Apr 202213513460
May 202214714654
Jun 202213813237
Jul 202210910131
Aug 2022562560100
Sep 202225524981
Oct 202217818159
Nov 202213313151
Dec 2022787525
Jan 2023939232
Feb 202313212537
Mar 20231007951
Apr 2023907940
May 2023807334
Jun 2023817224
Jul 20231028535
Aug 2023685630
Sep 2023906728
Oct 2023826830
Nov 2023786630
Dec 20231457721
Jan 2024795321
Feb 2024977532
Mar 20241128957
Apr 20241089837
May 202412210232
Jun 2024675540
Jul 202414214054
Aug 202417816261
Sep 2024405398158
Oct 202416815382
Nov 20241058546
Dec 2024937451
Jan 20251008459
Feb 20251059655
Mar 2025968451
Apr 20251059651
May 2025998954
Jun 202520186
Total580053332050